Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
258.39
-3.09 (-1.18%)
Dec 5, 2025, 4:00 PM EST - Market closed
Labcorp Holdings Revenue
Labcorp Holdings had revenue of $3.56B in the quarter ending September 30, 2025, with 8.58% growth. This brings the company's revenue in the last twelve months to $13.77B, up 8.28% year-over-year. In the year 2024, Labcorp Holdings had annual revenue of $13.01B with 6.97% growth.
Revenue (ttm)
$13.77B
Revenue Growth
+8.28%
P/S Ratio
1.57
Revenue / Employee
$196,647
Employees
70,000
Market Cap
21.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13.01B | 847.30M | 6.97% |
| Dec 31, 2023 | 12.16B | 297.70M | 2.51% |
| Dec 31, 2022 | 11.86B | -1.27B | -9.68% |
| Dec 31, 2021 | 13.14B | -842.40M | -6.03% |
| Dec 31, 2020 | 13.98B | 2.42B | 20.98% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
LH News
- 3 days ago - Community Health Systems Completes Sale of Select Outreach Laboratory Assets to Labcorp - Business Wire
- 12 days ago - Labcorp Appoints Victor Bulto to Board of Directors - PRNewsWire
- 17 days ago - Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research - PRNewsWire
- 19 days ago - Lunit and Labcorp Announce Strategic Collaboration to Advance AI-Powered Digital Pathology Research - PRNewsWire
- 5 weeks ago - Labcorp Positioned For Gradual Upside With Resilient Margins And Dividend Support - Benzinga
- 5 weeks ago - Labcorp Holdings Inc. (LH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Labcorp lifts annual profit forecast on strong diagnostic test demand - Reuters
- 5 weeks ago - Labcorp Announces 2025 Third Quarter Results - PRNewsWire